Search
for
Sort by
Research 181–210 of 1000+
- Virilization from partner's use of topical androgen in a reproductive-aged woman
- Hirsutism
- Testosterone in Women: Measurement and Therapeutic Use
- Androgens/Androgen Receptor in the Management of Skin Diseases
- The Biology of Hair Growth
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Cutaneous manifestations of polycystic ovary syndrome
- Ethinylestradiol/Chlormadinone Acetate for Use in Dermatological Disorders
- Role of 5α-reductase inhibitors in androgen-stimulated skin disorders.
- Insulin resistance, nitric oxide, and fibrinogen levels in white hirsute women: Defining a new paradigm based on translational research
- Polycystic ovary syndrome
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
- Diagnosis and treatment of polycystic ovarian syndrome: an update
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Generalised Glucocorticoid Resistance
- A case of severe hyperandrogenism, acanthosis nigricans and overt diabetes: the use of non-invasive methods for diagnosis, pathogenesis and management
- Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome
- Acne in hirsute women
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Diagnosis of hyperandrogenism: clinical criteria
- Nonclassic adrenal hyperplasia
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Nonclassic Congenital Adrenal Hyperplasia
- Congenital Adrenal Hyperplasia
- Intracrinology and The Skin
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- HAIR AND SYSTEMATIC DISEASE
- ANTIANDROGEN TREATMENT OF POLYCYSTIC OVARY SYNDROME
- A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women.